peptideInjectable
AOD-9604
Half-life
0.5 h
Typical timing
morning
Food rule
empty stomach
Default unit
mcg
Studied for
Overview
AOD-9604 is a synthetic modified peptide fragment of human growth hormone (hGH) corresponding to amino acids 177-191. It was developed to mimic the fat-reducing effects of hGH without stimulating growth hormone receptors responsible for growth and insulin resistance, effects seen with intact hGH. Its primary area of investigation has been its potential role in fat metabolism and weight management (Source: PubChem, DrugBank). Early research focused on its ability to stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat accumulation) without impacting blood sugar levels or tissue growth. AOD-9604 is typically administered via injection and has a relatively short half-life.
Deep dive
Tap a section to expand.
Known interactions
- Category rule: peptide × hormoneNote
Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.
Track bloodwork with a provider; don't assume combinations are neutral.
Frequently asked
Sources referenced
* PubChem
* DrugBank
* ClinicalTrials.gov
* Examine.com
* Reports from various unverified research studies cited by third parties
Stackwise compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician.
Related compounds
Others in the peptide category or studied for the same goals.
Related benefits
Other compounds studied for the same benefits as AOD-9604.
Continue exploring
See every compound Stackwise catalogues for these goals.
Track AOD-9604 in Stackwise
Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.
Sign up free →